| Li Cui, | |
|
900 S Atlantic Blvd, Monterey Park, CA 91754 | |
| (323) 788-6538 | |
| Not Available |
| Full Name | Li Cui |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 900 S Atlantic Blvd, Monterey Park, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093193575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A144883 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monterey Park Hospital | Monterey park, CA | Hospital |
| San Gabriel Valley Medical Center | San gabriel, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gem Medical Group Corporation | 3072984400 | 51 |
| Emergency Physicians Of San Gabriel Valley | 4082023726 | 14 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Entity Name | Tahoe Emergency Physicians Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104937408 PECOS PAC ID: 0446151674 Enrollment ID: O20040120000328 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Entity Name | Michael S. Agron, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699716100 PECOS PAC ID: 2668360736 Enrollment ID: O20040707000788 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Entity Name | Golden West Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053680298 PECOS PAC ID: 8628098936 Enrollment ID: O20051201000582 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Entity Name | Emergency Physicians Of San Gabriel Valley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366021834 PECOS PAC ID: 4082023726 Enrollment ID: O20210507002497 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Entity Name | Gem Medical Group Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689364721 PECOS PAC ID: 3072984400 Enrollment ID: O20230124000274 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Li Cui, 1004 West Covina Pkwy 214, West Covina, CA 91790 Ph: () - | Li Cui, 900 S Atlantic Blvd, Monterey Park, CA 91754 Ph: (323) 788-6538 |
News Archive
Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.
› Verified 3 days ago
Dr. Jeremy Demetri Williams, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-307-2129 Fax: 626-307-2056 | |
Dr. Neil Katchman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 S Atlantic Blvd, Monterey Park, CA 91754 Phone: 714-522-2001 Fax: 714-522-7503 | |
Dr. Juan Carlos Jones, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-307-2129 | |
Dr. Dolores De Cruz, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-307-2129 Fax: 626-307-2056 | |
Kimberly Marie Iwaki, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 708 Barnum Way, Monterey Park, CA 91754 Phone: 626-390-1154 | |
Dr. Connie Chan, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-307-2129 Fax: 626-307-2056 |